Trial intelligence / Profile preview

Delayed Cord Clamping and Maternal Oxytocin Timing

ACTRN12615001299594Phase 4Recruiting

Sponsor
Monash Health
Start
Mar 2016
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 4, open-label trial of oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Monash Health. Primary endpoint: Neonatal arterial oxygen saturation. Started Mar 2016; status: recruiting.

02

Drugs

oxytocin
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on ACTRN12615001299594.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12615001299594.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call